Antisense-mediated inhibition of aminopeptidase N (CD13) markedly decreases growth rates of hematopoietic tumour cells.
Wex
T
T
Institute of Experimental Internal Medicine, Otto-von-Guericke University Magdeburg, Germany.
Lendeckel
U
U
Reinhold
D
D
Kähne
T
T
Arndt
M
M
Frank
K
K
Ansorge
S
S
D018826:CD13 Antigens / Q000037:antagonists & inhibitors / Q000235:genetics / Q000276:immunology*; D002455:Cell Division / Q000187:drug effects; D015971:Gene Expression Regulation, Enzymologic; D015972:Gene Expression Regulation, Neoplastic; D019337:Hematologic Neoplasms / Q000201:enzymology* / Q000235:genetics / Q000276:immunology / Q000473:pathology; D006801:Humans; D016376:Oligonucleotides, Antisense / Q000235:genetics / Q000494:pharmacology; D013601:T-Lymphocytes / Q000201:enzymology* / Q000276:immunology / Q000473:pathology*; D014407:Tumor Cells, Cultured
D016376:Oligonucleotides, Antisense; D018826:CD13 Antigens